Drug Master Files for: ANASTROZOLE
✉ Email this page to a colleague
ANASTROZOLE Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 18335 | A | II | 5/6/2005 | SCINOPHARM TAIWAN LTD | ANASTROZOLE USP |
| 19025 | A | II | 12/13/2005 | ALCAMI WISCONSIN CORP | ANASTROZOLE |
| 19034 | A | II | 12/16/2005 | TEVA PHARMACEUTICAL INDUSTRIES LTD | ANASTROZOLE |
| 19496 | I | II | 4/30/2006 | TAI HENG INDUSTRY CO LTD | ANASTROZOLE |
| 19687 | A | II | 8/11/2006 | NATCO PHARMA LTD | ANASTROZOLE |
| 19748 | A | II | 2/7/2008 | CIPLA LTD | ANASTROZOLE USP |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
